F E A T U R E
REVOLUTIONISIN DIAGNOSIS : TOM ADVANCEMENTS FOR AMYLOID DE
Findings suggest the test can reduce the need for PET imaging in some patients with mild cognitive decline to enable therapeutic focus on non-Alzheimer ’ s disease causes , broadening access to quality evaluation and lowering healthcare costs .
32 www . intelligenthealth . tech